⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL204256 | 0.82 | — | — | |
| SCHEMBL29064564 | 0.78 | — | — | |
| SCHEMBL2582896 | 0.78 | — | — | |
| Tert-Butanol SCHEMBL583190 | 0.76 | — | — | |
| SCHEMBL3415021 | 0.75 | — | — | |
| SCHEMBL31418727 | 0.75 | — | — | |
| Tert-Butanol SCHEMBL14576807 | 0.73 | — | — | |
| SCHEMBL234200 | 0.70 | — | — | |
| SCHEMBL11651286 | 0.70 | THRB (0.39) | — | |
| SCHEMBL30552549 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8197937-B2 | Perfluoropolyether polymer grafted polyaniline containing intermediate transfer members | XEROX CORPORATION (US) | 2012-06-12 | — | — | US | disclosed |
| US-8129025-B2 | Fluorotelomer grafted polyaniline containing intermediate transfer members | XEROX CORPORATION (US) | 2012-03-06 | — | — | US | disclosed |
| US-20100249322-A1 | FLUORINATED SULFONIC ACID POLYMER GRAFTED POLYANILINE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100247918-A1 | PERFLUOROPOLYETHER POLYMER GRAFTED POLYANILINE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100247919-A1 | FLUOROTELOMER GRAFTED POLYANILINE CONTAINING INTERMEDIATE TRANSFER MEMBERS | XEROX CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |